Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is someone panicking?
It's hilarious to see two FUDsters communicating, who've been exposed. 👺
It doesn't have to be a valid lawsuit. It's a smokescreen as cover for an organized short attack. No different than the lying pre-scripted hit pieces that AF puts out... as well as all the FUD spewed on this board.
These HF manipulators work every angle to create a short-n-distort opportunity. They have 20M collusive shorts to cover.
You continue to demonstrate how much of a 🤡 you are.... and voted so!
You're freakin' hilarious! 👺
Why are all of your 'likes' only from your fellow FUDsters? Hmmm...
You forgot the rest of it... "their handlers do." FUDsters just provide a smokescreen, while their HF handlers control the price. But you know this...
Many of my fellow investors here consider my FUDster-IDing efforts very noble and needed.
Unfortunately, you've been ID'd as such by your nonsense postings. You're just 1 of 33+
I can tell it really bothers you to be exposed 👺 and your toes stepped on. OUCH!
Shows how little you know... 👺
It's more than that... and quite obvious. Real investors know it takes time to work with RAs, review all the data, and get the nod to submit MAAs and NDAs. It's coming, so the continual bellyaching is just nonsense FUD.
That looks like last year's number...
12/29/2023... 20,073,365
This year being near term... yes... soon after approval. But no FUDster will acknowledge that likelihood, will you?
Calling you out.. yes or no?
Nope... I only call out the obvious lying FUD from the list of perpetual FUDsters. 👺
Y'all are a dead giveaway, due to the fact that you have NOTHING good to say... and you keep hanging around.
Funny, how only you FUDsters try to take me on... because y'all hate being called out.
It's monotonous 👺 day in, day out... because it's your job. Your bosses must be hell to work for.
Correct, FUD posts don't move the price; they're just smokescreen for the collusive HF manipulation behind the scenes (i.e. your handlers). It's common knowledge...
At least a dozen out of the 33 on the 👺 list... but I'm sure I'm missing some.
Call me the FUD moderator who has to look at all FUD posts. It's like septic system work... but someone has to do it.
Hey, 👺, their drug pipeline IS the SigmaCeptor platform, moron!
FUDsters can't accept reality... so they continue to spew lies and concoct false narratives. 👺
Your FUD mantra is really getting old. 👺 I guess that's what happens when your bosses crack the whip!
FUDsters hate being called out, don't you?
Then the use of emojis are very fitting for you... and aptly applied. 👺
FUDsters don't like the relaxed TOS rules that allow posters to call them out.
There're quite a lot of you... and working hard! 👺
Don't sell yourself short. You're a tremendous FUDster. 👺
However, you're no "real" investor. 👺
I haven't been as optimistic about Anavex as I am right now... awaiting MAA and NDAs toward commercialization.
Appears the SP is recovering quite well from the organized takedown. How could that be?
The frustration is clearly in the minds of your FUD team, as you/they try hard to twist negative narratives for your handlers, who'll have to begin covering their collusive short positions before more news drops.
Hey, 👺, It's called building a platform... the SigmaCeptor platform.
The work is completed for 2-73, except to file the MAA and NDAs.
It's the right time to begin advancing 3-71. Great strategy!
LOL! It's clearly the FUDsters who are entering panic mode. Just look at today's compilation of nonsensical FUD posts... yours included.
How did I fail to add you to the paid FUDster list? A terrible oversight on my part... my bad. Fixed it!
Put you toward the top! And at your FUD rate, you just might overtake BIOClown as top 👺
And what are you the king of?
Good publicity for Anavex; however, I find it rather curious that the article was carefully written to not mention the successful AD trial results, which should've received primary coverage. I wonder why? Might there be some political motivation behind it?
Investor will say it's the work of the cabal.
Success is success no matter how you spell it. It's quite clear that 2-73 is a very effective treatment for AD and Rett. Just ask the patients.
It is to me
Don't bother
Not at these manipulated low prices...
The FUD choir is out in force this morning earning their Judas coins.
Don't need ADL mean score when they have CDR-SB and ADAS-Cog, both, with p < 0.025... plus the strong responders who IMPROVED over identified threshold levels and other QoL improving aspects. But FUDsters like to focus on the one little piece of data.👺
The Rett data in total, along with QoL improvements in the lives of the patients will be what moves blarcamesine to approval... yes.
Good post, jt. If Anavex had any concerns with 2-73, we'd be seeing 3-71 starting Rett or AD trials, not schizophrenia.
It's clear that 3-71 has favorable M1 activation, in addition to S1R, to make it more optimal for schizophrenia therapy.
Though, it's very likely we'll see a future AD P3 trial with 3-71, only after 2-73 has been approved and producing large revenue.
Building out the value proposition with two drugs.
Nice FUD spin...
Hey, 🤡, this is the AVXL board, not NFLX or NVDA (which I own)
1) ADAS-Cog and CDR-SB (p < .025), proving further evidence of stat. sig. improvements and trial success, was for combined treatment arms. Therefore, your dose-level concern is irrelevant to this measure.
2) Missling stated mid last year that they felt it worthwhile to wait for the Excellence results, before preceding further with AD, in order to secure the voucher. Now that the Excellence results are in, we're seeing Anavex moving forward with AD... with the EMA and soon with the FDA.
Anavex is more concerned with impressing RAs with the full data, than a few worrisome shareholders.
Expect to see the full P2b/3 data in the upcoming peer-reviewed article.
Who's the bullshitter?